Versor Investments LP’s Trillium Therapeutics Inc Position
Does Versor Investments LP own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 1.92M shares worth $34M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$34M
Q3 2021
Shares
1.92M
% of Portfolio
+1.04%
Quarters Held
1
position exited
Position History TREUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2021 | 1.92M | $34M | +1.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versor Investments LP’s full portfolio or all institutional holders of TREUR.